Welcome To Consumer Advocacy News

Jury Told J&J Should Have Warned About Cancer Risk Since 1982

baby powder cancer trial

The jury in the fourth baby powder cancer trial listened to the expert testimony of David C. Steinberg last week, who believes Johnson & Johnson (J&J) should have warned consumers of the risk of ovarian cancer as far back as 1982.

Mr. Steinberg pointed out to the jury that a 1982 study provided sufficient evidence that the talc in baby powder could cause ovarian cancer. The 1982 study combined with studies published throughout the previous decade should have made J&J aware of the cancer link.

Mr. Steinberg also disagreed with the company’s attitude toward conducting studies to determine talc’s safety in the 1990s. According to internal J&J documents, in 1994, the company didn’t want to pay for studies evaluating talcum powder. Instead, J&J wanted the studies to be funded by the government. Because the cosmetic industry is largely unregulated by the U.S. Food and Drug Administration (FDA), Mr. Steinberg believes it was J&J’s responsibility to conduct the studies themselves.

Also implicated in the trial is J&J’s talc supplier, Imerys S.A., which Mr. Steinberg believes should have given J&J an ultimatum: include a warning of the cancer risk, or Imerys would stop supplying talc.

While talc has been used in baby powder for more than 100 years, there are safer alternatives available. J&J has sold cornstarch-based baby powder since the 1970s, but talc-based baby powder continues to be the company’s bread and butter in its baby products division sales numbers.

What is Talc?

Talc is a naturally occurring mineral composed of mostly magnesium, oxygen, and silicone. When ground into a powder, it is commonly used to absorb moisture and prevent rashes on the skin. Because of its moisture-absorbing properties, talc is a popular ingredient in many cosmetic products, but studies dating as far back as 1971 have suggested using talc around the groin can cause ovarian cancer.

Exit mobile version